# Adversarial Review Panel: Stress-Test of Paper Proposal

**Paper:** Self-Directed Discovery of Molecular Transformer Architectures via Recursive Self-Refinement
**Target venue:** NeurIPS 2026
**Date of review:** 2026-03-09

---

## Reviewer 1: NAS Specialist

**Overall Score: 4/10 (Borderline Reject)**

### Summary

The authors propose using an LLM coding agent (forked from Karpathy's autoresearch) to iteratively refine transformer architectures for molecular sequence modeling (SMILES, protein sequences). The central claim is that this "Recursive Self-Refinement" approach is fundamentally different from standard NAS because the search space is unbounded code edits rather than a predefined architecture space. While the application domain is interesting, the novelty claims are significantly overstated given the existing literature on LLM-guided program synthesis for architecture search.

### Strengths

1. **Clear experimental design.** Three parallel tracks (SMILES, Protein, NLP control) with a shared methodology allows clean comparison of architectural preferences across domains.
2. **Practical budget consciousness.** The $72 AWS estimate and 5-minute training windows make this accessible, which is valuable for the community.
3. **Interesting question at the core.** Whether molecular data induces structurally different optimal architectures than natural language is a genuinely interesting scientific question.

### Weaknesses

1. **The "unbounded code edits" claim is not novel -- it is program synthesis NAS.** EvoPrompting (Chen et al., NeurIPS 2023) already demonstrated LLM-guided neural architecture search where the LLM proposes architecture code in an evolutionary loop. The search space there is also "unbounded" in the sense that the LLM can generate arbitrary PyTorch code. The proposed method is a direct instance of this paradigm. The authors must engage with this work head-on and explain what is different.

2. **FunSearch (Romera-Paredes et al., Nature 2024) directly undermines the novelty framing.** FunSearch uses an LLM to iteratively generate and refine programs, evaluated against a scoring function, with the best programs kept in a pool. This is structurally identical to the proposed "Recursive Self-Refinement" loop (agent refines code -> evaluate -> keep/discard -> repeat). The authors' claim to have coined a novel concept is untenable without distinguishing from FunSearch's "searching in function space."

3. **GPT-NAS (2024) and GENIUS (2024) already combine LLMs with architecture search.** GPT-NAS uses GPT-4 to propose architectures. GENIUS (Zheng et al., 2024) uses LLMs as evolutionary operators for NAS. The "novel intersection" of {LLM coding agent} x {architecture discovery} is well-explored.

4. **OpenELM (Lehman et al., 2024) from Google DeepMind uses LLMs to evolve code across diverse domains.** This directly addresses the "unbounded code edit" search space and has been applied beyond NLP tasks.

5. **The IMPROVE framework (2025), which they cite, already demonstrates LLM-driven iterative code refinement for ML research.** If they cite it as related work, what is the delta? The only difference appears to be the application domain (molecular data), which is incremental.

6. **"Recursive Self-Refinement" is not a novel term.** Self-Refine (Madaan et al., NeurIPS 2023) coined "iterative self-refinement" for LLM outputs. The addition of "recursive" is cosmetic. The concept of an agent iteratively improving an artifact based on feedback is well-established in the self-improvement and self-play literature. Claiming terminological novelty here would invite derision from reviewers.

7. **No formal characterization of the search space or search dynamics.** Standard NAS papers characterize their search space, provide theoretical or empirical analysis of search efficiency, and compare against well-defined baselines. This proposal treats the search process as a black box ("the LLM decides what to change"), making it impossible to analyze convergence properties, search space coverage, or optimality guarantees.

8. **Missing critical baselines.** The proposal compares against random NAS and grid search (H4), but the real baselines should be: (a) EvoPrompting applied to the same molecular tasks, (b) standard weight-sharing NAS (e.g., DARTS, OFA) on SMILES, (c) a human expert given the same time budget. Without these, the contribution cannot be assessed.

### Questions for Authors

1. What specifically distinguishes your method from EvoPrompting applied to molecular architectures? Is the contribution the method or the domain?
2. If the contribution is the domain (molecular data), why not simply run EvoPrompting on SMILES and report what architectures emerge?
3. How do you handle the non-determinism of the LLM agent? Different API calls may yield completely different search trajectories. Is this a feature or a confound?
4. Can you characterize the effective search space the agent explores? What fraction of edits are architectural vs. hyperparameter changes vs. training recipe changes?

### Missing References

- **EvoPrompting** (Chen et al., NeurIPS 2023) -- LLM-guided evolutionary NAS with code generation
- **FunSearch** (Romera-Paredes et al., Nature 2024) -- LLM-driven program search with iterative refinement
- **OpenELM** (Lehman et al., 2024) -- Evolution through Large Models, code-level search
- **GENIUS** (Zheng et al., 2024) -- LLMs as evolutionary operators for NAS
- **LLM-based NAS survey** (multiple 2024-2025 works consolidating this subfield)
- **AlphaCode / AlphaCode 2** -- LLM program synthesis at scale (relevant to "unbounded code" framing)
- **The AI Scientist** (Lu et al., 2024) -- End-to-end automated scientific discovery including architecture modification

### Actionable Recommendations

1. **Reframe the contribution honestly.** This is "LLM-guided program synthesis NAS applied to molecular domains" -- not a new paradigm. That is still a valid contribution if the domain-specific findings are interesting.
2. **Add EvoPrompting and FunSearch as direct baselines**, not just related work.
3. **Drop the "novel term" claim** for Recursive Self-Refinement. It will antagonize reviewers.
4. **Characterize the search space** by logging and categorizing all edits the agent makes across runs.
5. **Strengthen the domain contribution** by adding molecular-specific evaluation metrics beyond val_bpb (see Reviewer 2).

---

## Reviewer 2: Computational Biology

**Overall Score: 3/10 (Reject)**

### Summary

This proposal applies an LLM-driven architecture search to find optimal transformer designs for molecular sequence modeling, using validation bits-per-byte (val_bpb) on SMILES strings as the optimization target. While the automation angle is interesting, the proposal reveals a fundamental disconnect with the computational biology and drug discovery communities: optimizing next-token prediction on SMILES strings is a deeply questionable proxy for any meaningful molecular task, and the proposal makes no attempt to validate that improved val_bpb translates to improved molecular understanding.

### Strengths

1. **Cross-domain comparison is valuable.** Comparing architectures that emerge for SMILES vs. protein vs. NLP could reveal genuine insights about how data modality shapes optimal architecture.
2. **Protein track has clearer motivation.** Autoregressive protein language models (e.g., ProGen, ESM-2 variants) have demonstrated utility, so architecture search in this space has more direct value.
3. **Low barrier to entry.** The methodology could be replicated by computational chemistry labs without deep NAS expertise.

### Weaknesses

1. **Val_bpb on SMILES is not a meaningful metric for molecular modeling.** SMILES is an arbitrary string encoding of molecular graphs. A model that achieves low perplexity on SMILES strings has learned SMILES syntax and common substructure statistics -- not molecular properties, binding affinity, reactivity, or any chemically meaningful quantity. The proposal conflates language modeling quality with molecular understanding.

2. **Autoregressive modeling of SMILES is the wrong paradigm for most molecular tasks.** The dominant successful molecular language models use masked language modeling (MLM), not autoregressive generation:
   - **MolBERT** (Fabian et al., 2020) -- BERT-style MLM on SMILES for property prediction
   - **ChemBERTa** (Chithrananda et al., 2020) -- RoBERTa on SMILES
   - **MoLFormer** (Ross et al., Nature Machine Intelligence 2022) -- linear attention Transformer with MLM
   - **Uni-Mol** (Zhou et al., ICLR 2023) -- 3D molecular pretraining

   Autoregressive SMILES generation is primarily used for molecular generation (e.g., REINVENT), not representation learning. The proposal never clarifies which downstream task matters.

3. **SMILES is a fundamentally limited molecular representation.** The field has largely moved toward:
   - **3D structure-aware models:** SchNet, DimeNet, DimeNet++, PaiNN, GemNet, Equiformer
   - **Molecular graph representations:** GIN, AttentiveFP, GPS++
   - **SE(3)-equivariant architectures:** EGNN, TFN, MACE
   - **Hybrid approaches:** Uni-Mol (3D + Transformer)

   Searching for optimal SMILES transformer architectures is optimizing within an outdated paradigm. A NeurIPS 2026 paper that ignores 3D/graph approaches will be seen as out of touch.

4. **ZINC-250K is inadequate.** This dataset contains ~250,000 drug-like molecules. Modern molecular datasets include:
   - ZINC-22: >37 billion molecules
   - PubChem: >100 million compounds
   - GEOM-Drugs: 300K+ 3D conformers
   - OGB molecular benchmarks

   Architecture search on 250K molecules risks overfitting to a narrow chemical space. Findings may not generalize.

5. **No downstream task evaluation.** The proposal measures only val_bpb. For a molecular modeling paper to be credible, it must evaluate on:
   - Molecular property prediction (MoleculeNet benchmarks: BBBP, HIV, Tox21, etc.)
   - De novo molecular generation quality (validity, uniqueness, novelty, drug-likeness)
   - Scaffold hopping or molecular optimization
   - Binding affinity prediction (if claiming drug discovery relevance)

   Without downstream evaluation, the paper cannot support any claim about molecular modeling utility.

6. **H3 (SMILES-to-protein transfer) is poorly motivated.** SMILES and protein sequences have fundamentally different structures. SMILES encodes covalent bond topology with branch/ring notation; protein sequences encode linear amino acid chains with long-range 3D contacts. Why would architectural preferences transfer? The hypothesis needs stronger biological motivation.

7. **No comparison with molecular-specific architectural innovations.** The field has produced domain-specific architectural insights:
   - Rotary position embeddings for sequence length generalization
   - 3D-aware attention biases (AlphaFold2-style)
   - Multi-scale attention for proteins (MSA Transformer)
   - Chemical bond-aware attention masks

   The agent is unlikely to discover these without inductive biases pointing toward molecular structure.

### Questions for Authors

1. If the agent discovers an architecture with 5% better val_bpb, how would you determine whether this translates to better molecular representations? What is the validation plan?
2. Why autoregressive and not masked language modeling, given that MLM dominates molecular property prediction?
3. Have you considered using molecular graph transformers (e.g., Graphormer, GPS++) as the base architecture instead of a sequence transformer?
4. What evidence supports H3 (SMILES-to-protein transfer)? Can you cite any prior work showing architectural transfer between these modalities?
5. How do you account for the fact that SMILES has multiple valid representations per molecule (canonical vs. randomized), which fundamentally changes the learning problem?

### Missing References

- **MoLFormer** (Ross et al., Nature Machine Intelligence 2022) -- Directly relevant: Transformer for molecular SMILES with architectural innovations
- **Uni-Mol** (Zhou et al., ICLR 2023) -- 3D pretraining, represents the direction the field has moved
- **Graphormer** (Ying et al., NeurIPS 2021) -- Graph Transformer, alternative paradigm
- **GPS++** (Masters et al., 2023) -- General Powerful Scalable graph transformer
- **Equiformer** (Liao & Smidt, ICLR 2023) -- Equivariant Transformer for 3D molecular modeling
- **REINVENT** (Olivecrona et al., 2017; Blaschke et al., 2020) -- Standard autoregressive SMILES generation
- **MoleculeNet** (Wu et al., 2018) -- Standard molecular benchmark suite
- **AlphaFold2** (Jumper et al., 2021) -- Protein-specific architectural innovations
- **ESM-2** (Lin et al., 2023) -- Protein language model at scale

### Actionable Recommendations

1. **Add downstream molecular benchmarks.** At minimum, evaluate discovered architectures on MoleculeNet property prediction tasks after pretraining.
2. **Include molecular generation metrics.** If sticking with autoregressive SMILES, evaluate validity, uniqueness, novelty, and distributional metrics (FCD, KL divergence of property distributions).
3. **Scale up the dataset.** Use at least ZINC-15 (a few million compounds) or PubChem-10M. ZINC-250K is a toy dataset by 2026 standards.
4. **Add a graph/3D baseline.** Show that the SMILES Transformer architectures the agent discovers are competitive with (or complementary to) GNN/3D approaches on at least one molecular task.
5. **Justify the autoregressive choice** with a clear downstream application (molecular generation) and evaluate accordingly.
6. **For the protein track,** use established protein benchmarks (TAPE, PEER, or the ProteinGym benchmarks) to validate that better val_bpb means better protein understanding.

---

## Reviewer 3: Reproducibility Specialist

**Overall Score: 3/10 (Reject)**

### Summary

The proposal describes an automated architecture search driven by an LLM coding agent. While the concept is appealing, the experimental design has critical reproducibility flaws: reliance on a closed-source, non-deterministic LLM as the core search mechanism; insufficient statistical rigor with only 3 runs per track; a training budget too short to learn meaningful representations; and a dataset too small to support the claims.

### Strengths

1. **Open-source base.** Forking from Karpathy's autoresearch provides a public starting point that others can build on.
2. **Low compute budget.** The $72 budget makes this theoretically accessible, which is refreshing in an era of million-dollar experiments.
3. **Multiple tracks.** Running SMILES, protein, and NLP tracks provides internal controls.

### Weaknesses

1. **Closed-source LLM as the search engine is a fundamental reproducibility barrier.** The core scientific contribution -- what architectures the agent discovers -- depends entirely on the behavior of a proprietary, versioned, non-deterministic API (likely Claude or GPT-4). Specific problems:
   - **Model versioning:** GPT-4-0613, GPT-4-turbo, GPT-4o, Claude 3, Claude 3.5 all behave differently. Results from one version may not replicate on another. By the time the paper is reviewed, the model version used may be deprecated.
   - **Non-determinism:** Even with temperature=0, these APIs are not fully deterministic due to batching, quantization, and infrastructure changes. The same prompt can yield different code edits.
   - **Irreproducibility by design:** No other researcher can replicate the exact search trajectory. They can run the same framework but will get different results. This makes the specific architectural findings non-reproducible.
   - **Rate limits and costs:** API behavior, rate limits, and pricing change over time, affecting feasibility of replication.

2. **5-minute training budget is insufficient for meaningful architecture evaluation.** Consider what 5 minutes on an A10G buys:
   - At ~1000 tokens/sec throughput for a small transformer, 5 minutes = ~300K tokens processed
   - For ZINC-250K with average SMILES length ~50 characters, this is roughly 6K molecules seen
   - This is insufficient to learn molecular syntax, let alone molecular semantics
   - Val_bpb after 5 minutes primarily measures ease of optimization (how fast loss drops), not final model quality
   - **The agent is optimizing for architectures that train fast, not architectures that learn well.** These are different objectives. Architectures with good inductive biases might need longer to converge but achieve better final performance.

3. **3 runs per track is grossly insufficient for statistical claims.** With 3 runs:
   - You cannot compute meaningful confidence intervals
   - You cannot distinguish signal from noise in architectural preferences
   - Standard practice in NAS papers is 5-10 independent runs minimum, with many using 100+ for statistical NAS benchmarks
   - H1 claims architectures "will differ" -- with n=3, how do you establish this is a consistent finding rather than random variation?
   - The proposal claims ~100 experiments per run, but these are sequential and correlated (each experiment depends on the previous agent state), so they are not independent samples

4. **ZINC-250K is too small and biased.**
   - This is a curated subset of drug-like molecules with specific property filters (logP, MW, etc.)
   - Architectural preferences discovered on this narrow distribution may not generalize to broader chemical space
   - By 2026 standards, this is a debugging dataset, not a research dataset

5. **No ablation or control for the LLM agent's biases.** The LLM agent has been trained on vast amounts of code, including existing transformer architectures, NAS papers, and molecular modeling code. The "discoveries" may simply reflect the agent's training data priors rather than being driven by the molecular data. Controls needed:
   - Run the same agent with random/corrupted SMILES to see if similar architectures emerge (testing whether the data matters at all)
   - Run with a different LLM (e.g., open-source Llama/Mixtral) to test whether findings are LLM-dependent
   - Compare agent-discovered architectures against the most common architectures in the agent's training data

6. **"~100 experiments each" is vague.** Is 100 a target, a cap, or an estimate? What determines when a run terminates? If the agent can run indefinitely, what is the stopping criterion? If it is wall-clock time, that couples the science to the hardware.

7. **No versioning or logging protocol specified.** For reproducibility, the paper must:
   - Log every prompt sent to the LLM and every response received
   - Version-pin the LLM API
   - Record all random seeds
   - Store every intermediate train.py version
   - Report wall-clock times for each experiment

   None of this is mentioned.

### Questions for Authors

1. Which LLM will serve as the agent? Will you version-pin it? What happens when that version is deprecated?
2. Have you validated that 5-minute training runs rank architectures in the same order as full training runs? This is a critical assumption that requires empirical validation (e.g., correlation between 5-min val_bpb and 1-hour val_bpb across architectures).
3. With 3 runs, what statistical test will you use to support H1-H4? What is the minimum effect size you can detect?
4. Will you release all agent logs (prompts, responses, code diffs) for reproducibility?
5. How do you control for the LLM agent's prior knowledge of transformer architectures? The agent may simply recreate architectures it has seen in training data.

### Missing References

- **NAS-Bench-101/201/301** -- Standard reproducible NAS benchmarks; the proposal should discuss why it cannot use analogous tabular benchmarks
- **Reproducibility crisis in NAS** (Yang et al., 2020; Yu et al., 2020) -- Showed that many NAS papers had reproducibility issues even with deterministic search algorithms
- **The AI Scientist** (Lu et al., 2024) -- Uses LLMs for automated research; discusses reproducibility challenges
- **Open-source LLM alternatives** -- Llama 3, Mixtral, DeepSeek -- the proposal should discuss whether open-source agents could be used

### Actionable Recommendations

1. **Use an open-source LLM as the agent** (e.g., Llama 3.1 70B, DeepSeek-V2, or Mixtral 8x22B). This is the single most important change for reproducibility. If proprietary LLMs are used, at minimum run a replication with an open-source model.
2. **Validate the 5-minute proxy.** Before the main experiment, run a calibration study: train 20-30 architectures for both 5 minutes and 2 hours, then measure rank correlation. If the correlation is low, the entire experimental design is invalidated.
3. **Increase to at least 5 runs per track**, preferably 10. Report means, standard deviations, and confidence intervals for all claims.
4. **Scale up the dataset** to at least 1-2 million molecules.
5. **Log everything.** Release complete agent interaction logs as supplementary material. Record the exact LLM model version, API parameters, all prompts, all responses, all code diffs, all training curves.
6. **Add the corrupted-data control.** Run the agent on randomized SMILES strings (shuffled characters) to test whether the molecular structure of the data actually drives the architectural choices.
7. **Define clear stopping criteria** and experiment budgets that are not hardware-dependent.

---

## Reviewer 4: Devil's Advocate Synthesis

### Synthesized Assessment

**Aggregated Score: 3.3/10 -- Reject with encouragement to revise and resubmit.**

After reading all three reviews, I identify the following hierarchy of critiques, ranked by severity and difficulty of remediation.

### Fatal Critiques (Cannot be adequately answered without fundamental redesign)

**1. The optimization target (val_bpb on SMILES) is disconnected from molecular utility. (Reviewer 2, Weakness 1)**

This is the most damaging critique. The entire experimental apparatus optimizes a metric that the computational chemistry community does not consider meaningful for molecular understanding. Without downstream task evaluation, the paper cannot appear at NeurIPS as a molecular modeling contribution, and without molecular relevance, it is "just" another NAS paper -- where the novelty is weak (Reviewer 1). This creates a fatal catch-22: the paper needs the molecular angle for novelty, but the molecular angle requires evaluation the paper does not provide.

**Difficulty to fix:** High. Adding proper molecular benchmarks (MoleculeNet, generation metrics) requires significant additional compute and possibly a different experimental design (longer training, larger data).

**2. The 5-minute training proxy is unvalidated. (Reviewer 3, Weakness 2)**

The entire experimental design rests on the assumption that 5-minute training runs are a reliable proxy for architectural quality. This is likely false: short training runs favor architectures that converge quickly (good initialization sensitivity, simple loss landscapes) rather than architectures that learn the best representations. Known examples: deeper networks often train slower initially but outperform shallow ones given sufficient time. The proposal needs a calibration study, and if the correlation is poor, the entire approach collapses.

**Difficulty to fix:** Medium. A calibration study (train N architectures for 5 min and 2 hours, measure rank correlation) could be done within the budget. But if the correlation is low, there is no easy fix.

**3. Novelty claims are overstated relative to EvoPrompting, FunSearch, and OpenELM. (Reviewer 1, Weaknesses 1-3)**

The "Recursive Self-Refinement" framing and the claim of a "novel intersection" do not survive scrutiny. The method is a straightforward application of LLM-guided program synthesis (well-established by 2024) to a new domain (molecular data). This is an incremental contribution, not a paradigm shift. The paper as currently framed will be desk-rejected by NAS-savvy reviewers who recognize the prior art.

**Difficulty to fix:** Low, but requires intellectual honesty. Reframe as "we applied LLM-guided architecture search to molecular domains and found X" rather than claiming a new paradigm.

### Serious Critiques (Addressable but require substantial work)

**4. Reproducibility is fundamentally compromised by closed-source LLM dependence. (Reviewer 3, Weakness 1)**

This is a philosophical issue for the field, not just this paper. However, since the paper's contribution is the *specific architectures discovered*, and those discoveries are non-reproducible, the contribution is closer to an anecdote than a scientific finding. Using an open-source LLM would substantially mitigate this.

**5. ZINC-250K is too small and SMILES is too limited. (Reviewers 2 and 3)**

Both the dataset size and the representation choice are behind the state of the art. This can be partially fixed by scaling up the dataset and adding graph/3D baselines, but this changes the scope of the project.

**6. Statistical rigor is insufficient. (Reviewer 3, Weakness 3)**

Three runs cannot support the claims. This is fixable by increasing the number of runs but increases the budget.

### Moderate Critiques (Addressable with modest effort)

**7. H3 (SMILES-to-protein transfer) lacks motivation. (Reviewer 2, Weakness 6)** -- Can be removed or better motivated.

**8. No ablation for LLM prior knowledge. (Reviewer 3, Weakness 5)** -- Fixable with control experiments.

**9. Missing formal search space characterization. (Reviewer 1, Weakness 7)** -- Fixable with logging and post-hoc analysis.

### Potential Scooping Assessment

Based on the rapidly evolving field landscape:

- **The AI Scientist (Lu et al., ICML 2024)** already demonstrates end-to-end automated ML research including architecture modification. It has been applied to multiple domains. The recursive self-refinement loop described in this proposal is a subset of The AI Scientist's capabilities.
- **Autoresearch forks** have proliferated since Karpathy's release. Multiple groups have applied them to non-NLP domains. The authors need to survey this landscape carefully to establish what remains novel.
- **LLM + NAS is now a recognized subfield** with workshops at NeurIPS 2024 and ICML 2025. The window for "first to combine LLMs with architecture search" has closed.
- **Molecular transformer architecture search** specifically: there does not appear to be a published paper that uses LLM-guided program synthesis for molecular transformer NAS. This niche may still be open, but the contribution must be framed as domain-specific findings, not methodological novelty.

### Path Forward: Recommendations for a Viable Submission

If the authors want to target NeurIPS 2026, they should:

1. **Reframe as an empirical study, not a methods paper.** Title suggestion: "What Architectures Does an LLM Agent Discover for Molecular Sequences? An Empirical Study." Drop all claims of methodological novelty.

2. **Fix the evaluation.** Add MoleculeNet benchmarks and molecular generation metrics. This is non-negotiable for a molecular modeling paper.

3. **Validate the training proxy.** Run a calibration study before the main experiment.

4. **Use an open-source LLM** or at minimum replicate key findings with one.

5. **Scale up to ZINC-15 or PubChem-10M** and increase to 5+ runs per track.

6. **Add proper baselines:** EvoPrompting on the same tasks, standard NAS (DARTS or similar) on the same tasks, and manually designed molecular Transformers (MoLFormer, ChemBERTa).

7. **Focus the contribution on the findings, not the framework.** What architectural motifs does the agent discover for SMILES vs. NLP? Are there consistent patterns across runs? Do these match known molecular inductive biases? This is the interesting science -- the framework is infrastructure, not contribution.

8. **Add the corrupted-data control** to establish that discoveries are data-driven rather than reflecting LLM priors.

If these changes are made, the paper could become a solid empirical contribution. In its current form, it attempts to claim methodological novelty that does not exist, while lacking the domain-specific rigor needed to claim molecular modeling advances.

---

## Score Summary

| Reviewer | Score | Verdict |
|----------|-------|---------|
| Reviewer 1 (NAS Specialist) | 4/10 | Borderline Reject |
| Reviewer 2 (Comp Bio) | 3/10 | Reject |
| Reviewer 3 (Reproducibility) | 3/10 | Reject |
| **Aggregate** | **3.3/10** | **Reject** |

**Consensus recommendation:** Reject in current form. The core scientific question (do molecular sequences induce different optimal architectures?) is interesting, but the execution plan has critical gaps in evaluation methodology, statistical rigor, reproducibility, and novelty framing. A substantially revised version addressing the above critiques could be competitive for a future venue.
